ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-04548
製品名称
CDK4 Protein, Human, Recombinant (GST)
タンパク質名
CDK4
Species
Human
HOST
Baculovirus Insect Cells
50μg: -
お問い合わせ

Overview

Synonyms CMM3, PSK-J3, cyclin-dependent kinase 4
Characteristics No Kinase Activity
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 89%
Description CDK4 is a member of the Ser/Thr protein kinase family. It is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of CDK4 is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). CDK4 was shown to be responsible for the phosphorylation of retinoblastoma gene product. CDK4 is the ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. CDK4 has been shown to be mutated in some types of cancer, whilst a chromosomal rearrangement can lead to Cdk6 overexpression in lymphoma, leukemia and melanoma.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Reference Dai K,et al.(1996) Physical interaction of mammalian CDC37 with CDK4. J Biol Chem. 271(36): 22030-4.,Lamphere L,et al.(1997) Interaction between Cdc37 and Cdk4 in human cells. Oncogene. 14(16): 1999-2004.,Stepanova L,et al.(1996) Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10(12):1491-502.,Sugimoto M,et al.(1999) Regulation of CDK4 activity by a novel CDK4-binding protein, p34SEI-1. Genes Dev. 13(22):3027-33.
URL https://www.targetmol.com/recombinant-protein/cdk4_protein_human_recombinant_gst_tag_

お問い合わせリスト(-)

お問い合わせフォーム